TICKERNOMICS Sign up
Last Update: 2024-12-27 15:28:41
CalciMedica Inc. ( CALC )
3.01USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
CALC
2.73%
SPY
32.66%
-87.92%
CALC
SPY
108.59%
CALC
0.00%
SPY
302.52%
CALC
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
30.73
16.13
0.04
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-2.26
0.00
3.40
-63.49
0.00
-0.68
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
230.11
-706.75
0.00
Other Earnings and Cash Flow Stats:
CalciMedica Inc. ( CALC ) Net Income TTM ($MM) is -13.59
CalciMedica Inc. ( CALC ) Operating Income TTM ($MM) is -22.35
CalciMedica Inc. ( CALC ) Owners' Earnings Annual ($MM) is 0.00
CalciMedica Inc. ( CALC ) Current Price to Owners' Earnings ratio is 0.00
CalciMedica Inc. ( CALC ) EBITDA TTM ($MM) is -22.29
CalciMedica Inc. ( CALC ) EBITDA Margin is 0.00%
Capital Allocation:
CalciMedica Inc. ( CALC ) has paid 0.00 dividends per share and bought back -5.467621 million shares in the past 12 months
CalciMedica Inc. ( CALC ) has reduced its debt by 5.563 million USD in the last 12 months
Capital Structure:
CalciMedica Inc. ( CALC ) Interest-bearing Debt ($MM) as of last quarter is 0
CalciMedica Inc. ( CALC ) Annual Working Capital Investments ($MM) are -1
CalciMedica Inc. ( CALC ) Book Value ($MM) as of last quarter is 9
CalciMedica Inc. ( CALC ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
CalciMedica Inc. ( CALC ) has 9 million in cash on hand as of last quarter
CalciMedica Inc. ( CALC ) has 3 million of liabilities due within 12 months, and long term debt 0 as of last quarter
CalciMedica Inc. ( CALC ) has 11 common shares outstanding as of last quarter
CalciMedica Inc. ( CALC ) has 0 million USD of preferred stock value
Academic Scores:
CalciMedica Inc. ( CALC ) Altman Z-Score is -14.82 as of last quarter
CalciMedica Inc. ( CALC ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
CalciMedica Inc. ( CALC ) largest shareholder is BROWN BROTHERS HARRIMAN & CO owning 308 shares at 0.00 ($MM) value
MIDDLETON FRED A(an insider) Bought 4800 shares of CalciMedica Inc. ( CALC ) for the amount of $12720.00 on 2024-12-06
17.48% of CalciMedica Inc. ( CALC ) is held by insiders, and 43.87% is held by institutions
CalciMedica Inc. ( CALC ) went public on 2020-09-25
Other CalciMedica Inc. ( CALC ) financial metrics:
FCF:-31.32
Unlevered Free Cash Flow:0.00
EPS:-2.02
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-248.86
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About CalciMedica Inc. ( CALC ) :
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.